Search This Blog

Wednesday, August 22, 2018

Mallinckrodt receives complete response letter from FDA for NDA of stannsoporfin

https://bit.ly/2BE5Xik
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)